Three weeks into 2018, deal activity in the biotech sector is already almost halfway to what it was in 2017, at least in terms of size.
“You can always go faster than you think you can,” said Meg Whitman, outgoing Hewlett-Packard Enterprise CEO, at Davos in 2016.
CNBC's Meg Tirrell reports employees that go to work sick contribute to the further spread of influenza and lost productivity.
French drugmaker Sanofi is close to acquiring biotechnology company Bioverativ for $105 a share.
Flu is especially bad this season, and going into work while we're sick risks spreading flu further.
CNBC's Meg Tirrell breaks down factors from the worst flu season since 2010 and the effectiveness of the current flu shot.
Some states are reporting a higher number of deaths from flu this year than usual. CNBC's Meg Tirrell takes a look at how the medical community is dealing with the outbreak.
Johnson & Johnson CEO Alex Gorsky, a grandson of immigrants, talked to Meg Tirrell about the importance of the Dream Act to the company, which recently joined the Coalition for the American Dream in support of DACA recipients.
CNBC's Meg Tirrell speaks with Leonard Schleifer, Regeneron CEO, about how the company will benefit from tax cuts, as well as pricing competition among drug companies.
CNBC's Meg Tirrell speaks with Verily Chief Medical Officer Dr. Jessica Mega about the role Alphabet plays in the biotech company and what it could mean for the future of medicine.